In vitro and in vivo stability of 9-nitrocamptothecin lactone form in rats

Yaoxue Xuebao

Volumn 40, Issue 10, 2005, Pages 888-892

  Chen, Jun ^a   Ping, Qi Neng ^a   Guo, Jian Xin ^a   Liu, Lei ^a   Chu, Xiao Zhu ^a   Song, Ming Mei ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

9 nitrocamptothecin; HPLC; Lactone form; Pharmacokinetics; Stability

Indexed keywords

9-NITROCAMPTOTHECIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CARBOXYLIC ACID; DRUG DERIVATIVE; LACTONE; RUBITECAN;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; BLOOD; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METHODOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; CAMPTOTHECIN; CARBOXYLIC ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; LACTONES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 28444494060     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hertzberg RP, Caranfa MJ, Holden KG, et al. Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity [J]. J Med Chem, 1989,32(3):715-720.
2. Burke TG, MI Z. The structure basis of camptothecin interactions with human serum albumin: impact on drug stability [J]. J Med Chem, 1994,37(1):40-46.
3. Pan XD, Wang CY. Current status of camptothecin derivatives as natural antitumor agents [J]. Acta Pharm Sci, 2003,38(9):715-720.
4. Zhong DF, Li K, Xu JH, et al. Pharmacokinetics of 9-nitro-20 (S)-camptothecin in rats [J]. Acta Pharmacol Sin, 2003,24(3):256-262.
5. Cao Z, Harris N, Kozielski A, et al. Alkyl esters of camptothecin and 9-nitrocamptothecin: synthesis, in vitro pharmacokinetics, toxicity, and antitumor activity [J]. J Med Chem, 1998,41(1):31-37.
6. Scott DO, Bindra DS, Stella VJ. Plasma pharmacokinetics of the lactone and carboxylate forms of 20(S)-camptothecin in anesthetized rats [J]. Pharm Res, 1993,10(10):1451-1457.
7. Chow DS, Gong L, Wolfe MD, et al. Modified lactone/carboxylate salt equilibrium in vivo by liposomal delivery of 9-nitrocamptothecin [J]. Ann NY Acad Sci, 2000, 922:164-174.
8. Li YF, Zhang RW. Reversed-phase high performance liquid chromatography method for the simultaneous quantitation of the lactone and carboxylate forms of the novel natural product anticancer agent 10-hydroxycamptothecin in biological fluids and tissues [J]. J Chromatogr B, 1996,686:257-265.
9. Schoemarker NE, Rosing H, Jansen S, et al. Determination of 9-nitrocamptothecin and its metabolite 9-aminocamptothecin in human plasma using high-performance liquid chromatography with ultraviolet and fluorescence detection [J]. J Chromatogr B, 2002,775:231-237.
10. Huang Y, Liu SQ, Lin C, et al. Comparison of the pharmacokinetic characteristics of hydroxycamptothecin liposomes injection with market hydroxycamptothecin injection in rabbits after intravenous administration [J]. Acta Acad Med Mil Tert, 2004,26 (6):517-519.
11. Loos WJ, Sparreboom A, Verweij J, et al. Determination of the lactone and lactone plus carboxylate forms of 9-aminocamptothecin in human plasma by sensitive high-performance liquid chromatography with fluorescence detection [J]. J Chromatogr B, 1997,694:435-441.